Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2007-07-10
2007-07-10
Foley, Shanon (Department: 1648)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S069700, C435S328000, C530S350000
Reexamination Certificate
active
10899715
ABSTRACT:
HCV immunoassays comprising an NS3/4a conformational epitope and a multiple epitope fusion antigen are provided, as well as immunoassay solid supports for use with the immunoassays.
REFERENCES:
patent: 5350671 (1994-09-01), Houghton et al.
patent: 5683864 (1997-11-01), Houghton et al.
patent: 5712087 (1998-01-01), Houghton et al.
patent: 5843752 (1998-12-01), Dasmahapatra et al.
patent: 5871904 (1999-02-01), Kashiwakuma et al.
patent: 5990276 (1999-11-01), Zhang et al.
patent: 6171782 (2001-01-01), Houghton et al.
patent: 6428792 (2002-08-01), Valenzuela et al.
patent: 6514731 (2003-02-01), Valenzuela et al.
patent: 6630298 (2003-10-01), Chien et al.
patent: 2003/0044774 (2003-03-01), Valenzuela et al.
patent: 318216 (1989-05-01), None
patent: 388232 (1990-09-01), None
patent: 0450931 (1991-10-01), None
patent: 0472207 (1992-02-01), None
patent: 0 870 830 (1998-10-01), None
patent: 2 212 511 (1989-07-01), None
patent: 2 257 784 (1993-01-01), None
patent: 97 247 (1997-07-01), None
patent: WO 93/00365 (1993-01-01), None
patent: WO 94/01778 (1994-01-01), None
patent: WO 94 25601 (1994-11-01), None
patent: WO 97 12043 (1997-04-01), None
patent: WO 97/44469 (1997-11-01), None
Beld et al., “Evaluation of automated RNA-extraction technology and a qualitative HCV assay for sensitivity and detection of HCV RNA in pool-screening systems,”Transfusion40:575-579, 2000.
Chen et al., “Human and murine antibody recognition is focused on the ATPase/helicase domain, but not the protease domain of the hepatitis C virus non-structural 3 protein,”Hepatology28:219-224, 1998.
Chien et al., “Diagnosis of Hepatitis C Virus (HCV) Infection Using an Immunodominant Chimeric Polyprotein to Capture Circulating Antibodies: Reevaluation of the Role of HCV in Liver Disease,”Proc. Natl. Acad. Sci. U.S.A.89:10011-10015 (1992).
Chien et al., “Use of Recombinant HCV Antigen in the Serodiagnosis of Hepatitis C Virus Infection: Significant Improvement in HCV Antibody Detection as Compared with the First Generation HCV C100-3 ELISA and the Synthetic Peptide EIA Tests,”Jorunal of Gastroenterology Hepatology8:S33-39 (1993).
Chien et al., “Distinct subtypes of hepatitis C virus defined by antibodies directed to the putative core, NS4, and NS5 region polypeptides,”Virol. Hepatitis and Liver Disease:320-324, 1994.
Choo et al., “Isolation of a cDNA Clone Derived from a Blood-Borne Non-A, Non-B Viral Hepatits Genome,”Science244:359-362 (1989).
Choo et al., “Hepatitis C Virus: The Major Causative Agent of Viral Non-A, Non-B Hepatitis,”British Medical Bulletin46(2):423-441 (1990).
Cruse et al., Illustrated Dictionary of Immunology, CRC Press, Boca Raton FL, 1995, p. 76.
Ebeling et al., “Recombinant Immunoblot Assay for Hepatitis C Virus Antibody as Predictor of Infectivity,”Lancet335:982-983 (1990).
Houghton et al., “Molecular Biology of the Hepatitis C Viruses: Implications for Diagnos, Development and Control of Viral Disease,”Hepatology14:381-388 (1991).
Kotwal et al., “Detection of acute hepatitis C virus infection by ELISA using a synthetic peptide comprising a structural epitope,”Proc. Natl. Acad. Sci. USA89:4486-4489, 1992.
Kuo et al., “An Assay for Circulating Antibodies to a Major Etiologic Virus of Human Non-A, Non-B Hepatitis,”Science244:362-364 (1989).
Pereboeva et al., “Hepatitis C Epitopes From Phage-Displayed cDNA Libraries and Improved Diagnosis with a Chimeric Antigen,”J. Medical Virology60:144-151, 2000.
van der Poel et al., “Infectivity of Blood Seropositive for Hepatitis C Virus Antibodies,”Lancet335:558-560 (1990).
Van der Poel et al., “Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay,”Lancet337:317-319, 1991.
Yao et al., “Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase,” Structure 7(11):1353-1363, 1999.
Arcangel Phillip
Chien David Y.
Coit Doris
George-Nascimento Carlos
Medina-Selby Angelica
Foley Shanon
Harbin Alisa A.
Le Emily M.
Lillis Marcella
Novartis Vaccines and Diagnostics Inc.
LandOfFree
Immunoassays for anti-HCV antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunoassays for anti-HCV antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoassays for anti-HCV antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3772547